4.6 Article

PKM2-mediated inhibition of autophagy facilitates Tat's inducing HIV-1 transactivation

Journal

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
Volume 625, Issue -, Pages 17-23

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.abb.2017.05.018

Keywords

Tat; Autophagy; PKM2; AMPK

Funding

  1. practical training plan for the cross training of high level talents in Beijing Universities [2017070, 2017075]
  2. Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CITTCD201304054]
  3. National Natural Sciences Foundation of China [30800580]
  4. Beijing Nova Program [2007B014]

Ask authors/readers for more resources

Considerable evidence has shown that autophagy has an important role in HIV-1 infection. However, it is still unknown whether metabolism-regulated autophagy pathway is involved in Tat-mediated HIV-1 transactivation. This study demonstrated that treatment of Tat in TZM-bl cells significantly down regulated protein levels of Beclin-1, Atg-5, Atg-7, and LC3B-II and up-regulated of p62 levels. Blockage of autophagy enhanced Tat-induced HIV-1 transactivation in TZM-bl cells. Moreover, we found that Tat activated the Akt/mTOR and inhibited AMPK signaling pathway that was related to its up-regulation of PKM2 expression. In addition, we showed that PI3K/AKT activation and AMPK inhibtion was required for the PKM2-mediated inhibition of autophagy in Tat-treated TZM-bl cells. In conclusion, our data reveals that PKM2-mediated autophagy inhibition is required for Tat-mediated HIV-1 transactivation. Metabolism-related autophagic pathway may act as a promising diagnostic and therapeutic tool for HIV-1 infection in the future. (C) 2017 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available